PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

New approach prevents thrombosis without increasing the risk of bleeding

2014-02-06
(Press-News.org) Contact information: Press Office
pressinfo@ki.se
46-852-486-077
Karolinska Institutet
New approach prevents thrombosis without increasing the risk of bleeding In collaboration with an international team, researchers at Karolinska Institutet in Sweden have developed an antibody, 3F7, which blocks a protein that is active in the coagulation system factor XII. Inhibition of factor XII makes it possible to prevent thrombosis in blood vessels without increasing the risk of bleeding in clinical settings.

Thrombosis is caused by blood clotting; clots can block blood flow in one or more blood vessels and so cause thrombotic diseases such as stroke, myocardial infarction or pulmonary embolism. Today, thrombosis is prevented or treated by means of anticoagulants. There is a broad variety of anticoagulant drugs, such as warfarin (a vitamin K inhibitor), the novel oral anticoagulants (dabigatran or rivaroxaban) and drugs of the heparin group. All of these agents target different components of the blood coagulation system to prevent blood from clotting and thus to interfere with thrombosis. However, all these drugs also entail an increased risk of bleeding in patients that partially offsets their beneficial effects.

The blocking of coagulation factor XII (F XII) functions differently compared to traditional anticoagulants. It has been known for long time that humans that are deficient in FXII do not bleed excessively and because of that FXII was believed to have no function for blood coagulation in patients. In 2005, Thomas Renné and his research team discovered that mice lacking F XII could have neither a stroke nor pulmonary embolism, even though they had normal bleeding patterns.

"Since then, our goal has been to find an effective way to block F XII. Now, we have developed an antibody that blocks F XII in human blood, mice and rabbits", says Thomas Renné. "This provides protection against thrombosis without increasing the risk of bleeding."

Together with the doctoral student Magnus Larsson, the researchers developed and tested the antibody, called 3F7, in rabbits during an ECMO treatment. ECMO is an advanced heart-lung machine used in life-threatening conditions especially in infants. Contact with the plastic tubing causes the blood to clot, so patients are routinely administered with anticoagulants (heparin). However due to the heparin anticoagulation patients bleed excessively and a substantial number even dies from these bleedings.

In the study, thrombosis in rabbits on ECMO receiving 3F7 decreased was as low as rabbits receiving heparin, but the risk of bleeding with 3F7 was minimal, whereas heparin-treatment led to bleeding.

"Blocking F XII appears to be an effective strategy against thrombus formation, and we have shown this in experiments on rabbits in a clinically relevant context", says Thomas Renné. "There is a great need for a treatment that reduces the clot risk in emergency situations, such as during ECMO treatment and many others such as cardiovascular surgery. We plan to test the antibody in a phase I study. It is possible that the antibody also blocks inflammation mediated by F XII, an interesting area for future studies."

### The study was funded by Swedish Heart-Lung Foundation, Stockholm County Council (ALF), the Swedish Cancer Society, HRH Crown Princess Lovisa's Association for Child Medical Care, the Swedish Research Council, the German Research Society and the European Research Council. Several of those involved in the study are employees of the pharmaceutical company CSL Behring, which has consequently contributed to the study's inception.

Publication: 'A Factor XIIa Inhibitory Antibody Provides Thromboprotection in Extracorporeal Circulation Without Increasing Bleeding Risk', Magnus Larsson, Veronika Rayzman, Msarc W. Nolte, Katrin F. Nickel, Jenny Björkqvist, Anne Jämsä, Matthew P. Hardy, Marion Fries, Stefan Schmidbauer, Patricia Hedenqvist, Michael Broomé, Ingo Pragst, Gerhard Dickneite, Michael J. Wilson, Andrew D. Nash, Con Panousis and Thomas Renné, Science Translational Medicine, 5 February 2014 Vol 6 Issue 222 222ra17.

Contact the Press Office and download images: http://ki.se/pressroom

Website of the journal: http://stm.sciencemag.org/

Karolinska Institutet - a medical university: http://ki.se/english


ELSE PRESS RELEASES FROM THIS DATE:

Some receive unnecessary prioritization for liver transplantation, says Penn Medicine study

2014-02-06
(PHILADELPHIA) – Patients waiting for liver transplants ...

New analysis of endometriosis could help diagnoses, treatments

2014-02-06
CAMBRIDGE, MA -- Endometriosis, the invasive displacement of uterine tissue into surrounding organs, affects at least 10 percent of women. The disease, which is often misdiagnosed, can cause ...

Female mice prefer unfamiliar male songs

2014-02-06
Female mice prefer songs of mice that are different from their parents when selecting a mate, according to a study published February 5, 2014 in PLOS ONE by Akari Asaba from the Azabu University, ...

Mass extinction may not cause all organisms to 'shrink'

2014-02-06
The sizes of organisms following mass extinction events may vary more than previously thought, which may be inconsistent with the predictions of the so-called ...

Tree roots in the mountains 'acted like a thermostat' for millions of years

2014-02-06
For the first time, scientists have discovered how tree roots in the mountains may play an important role in controlling long-term global temperatures. Researchers from Oxford ...

New stem cell research removes reliance on human and animal cells

2014-02-06
A new study, published today in the journal Applied Materials & Interfaces, has found a new method for growing human embryonic stem cells, that doesn't rely on supporting human or animal cells. Traditionally, ...

Study shows yogurt consumption reduces the risk of type 2 diabetes

2014-02-06
New research published in Diabetologia (the journal of the European Association for the Study of Diabetes) shows that higher consumption of yoghurt, compared with no consumption, can reduce ...

Scientists create potential vaccine ingredient for childhood respiratory disease

2014-02-06
LA JOLLA, CA—February 5, 2014—Scientists at The ...

Social media analysis shows the Garment District still rules New York fashion

2014-02-06
A new study shows New York fashion designers don't just flock ...

Quarks in the looking glass

2014-02-06
From matching wings on butterflies to the repeating six-point pattern of snowflakes, symmetries echo through nature, even down to the smallest building blocks of matter. Since the discovery of quarks, the building ...

LAST 30 PRESS RELEASES:

Post-LLM era: New horizons for AI with knowledge, collaboration, and co-evolution

“Sloshing” from celestial collisions solves mystery of how galactic clusters stay hot

Children poisoned by the synthetic opioid, fentanyl, has risen in the U.S. – eight years of national data shows

USC researchers observe mice may have a form of first aid

VUMC to develop AI technology for therapeutic antibody discovery

Unlocking the hidden proteome: The role of coding circular RNA in cancer

Advancing lung cancer treatment: Understanding the differences between LUAD and LUSC

Study reveals widening heart disease disparities in the US

The role of ubiquitination in cancer stem cell regulation

New insights into LSD1: a key regulator in disease pathogenesis

Vanderbilt lung transplant establishes new record

Revolutionizing cancer treatment: targeting EZH2 for a new era of precision medicine

Metasurface technology offers a compact way to generate multiphoton entanglement

Effort seeks to increase cancer-gene testing in primary care

Acoustofluidics-based method facilitates intracellular nanoparticle delivery

Sulfur bacteria team up to break down organic substances in the seabed

Stretching spider silk makes it stronger

Earth's orbital rhythms link timing of giant eruptions and climate change

Ammonia build-up kills liver cells but can be prevented using existing drug

New technical guidelines pave the way for widespread adoption of methane-reducing feed additives in dairy and livestock

Eradivir announces Phase 2 human challenge study of EV25 in healthy adults infected with influenza

New study finds that tooth size in Otaria byronia reflects historical shifts in population abundance

nTIDE March 2025 Jobs Report: Employment rate for people with disabilities holds steady at new plateau, despite February dip

Breakthrough cardiac regeneration research offers hope for the treatment of ischemic heart failure

Fluoride in drinking water is associated with impaired childhood cognition

New composite structure boosts polypropylene’s low-temperature toughness

While most Americans strongly support civics education in schools, partisan divide on DEI policies and free speech on college campuses remains

Revolutionizing surface science: Visualization of local dielectric properties of surfaces

LearningEMS: A new framework for electric vehicle energy management

Nearly half of popular tropical plant group related to birds-of-paradise and bananas are threatened with extinction

[Press-News.org] New approach prevents thrombosis without increasing the risk of bleeding